Abstract
In order to prevent health risk from environmental chemicals, particularly for progeny, we have been performing a risk assessment for various chemicals including therapeutic agents. This paper reports the functional effects of maternal exposure to psychoactive drugs, anticancer drugs, or herbicides on the offspring of rats. Maternal exposure to imipramine in a dose equivalent to the therapeutic dose per unit body weight induced hyperthermic response to chlorpromazine in the male offspring, while normal control rats showed a marked hypothermia. Exposure to ethosuximide resulted in an increase in play fighting behavior in young offspring that was fostered by lactating normal mothers. Single exposures to nimustine or cisplatin, anticancer drugs, at a different gestational stage resulted in an acceleration of growth when exposed at the earlier stage of gestation. Moreover, cisplatin-exposed rats were emotionally unstable, showing a short latent time to the first line-crossing in an open-field during infantile period. The rats exposed to glufosinate ammonium, an herbicide, during the time of neurogenesis in the hippocampus showed a decrease in the wet-dog shakes response to kainic acid at six weeks of age. These results suggest that maternal exposure to chemicals during pregnancy induces a variety of functional abnormalities in the brain of the offspring dependent on the pharmacologic action of chemicals and the stage of gestation even with a single exposure.
Similar content being viewed by others
References
Martin JC, Martin DC, Radow B, Sigman G. Growth, development and activity in rat offspring following maternal drug exposure. Exper Aging Res 1976; 2: 235–51.
Fujii T, Adams PM, eds. Functional Teratogenesis: Func-tional Effects on the Offspring After Parental Drug Exposure. Tokyo, Japan: Teikyo University Press, 1987: 238.
Fujii T. Integrative assessment of the developmental phar-macology and developmental toxicology, with special reference to the brain. Folia pharmacol japon1991; 98: 419–34.
Chambers PL, Chambers CM, Bolt HM, Preziosi P, eds. Toxicology from Discovery and Experimentation to the Hu-man Perspective. Amsterdam, The Netherlands: Elsevier, 1992: 800.
Jones KL, Smith DW, Ulleland CN, Streissguth AP. Pattern of malformation in offspring of chronic alcoholic mother. Lancet 1973; i: 1267–71.
Kellogg C, Tervo D, Ison J, Parisi T, Miller RK. Prenatal exposure to diazepam alters behavioral development in rats. Science 1979; 207: 205–7.
Gupta C, Jaffe SJ, Shapiro BH. Prenatal exposure to phe-nobarbital permanently decreases testosterone and causes reproductive dysfunction. Science 1982; 216: 640–2.
Fujii T, Ohtaki Y. Sex-related hyperthermic response to chlorpromazine in the offspring of rats treated with imi-pramine. Dev Pharmacol Ther 1985; 8: 364–73.
Lin MT, Chern YF, Chow CF, Li YP. Effects of brain serotonin alterations on hypothermia produced by chlor-promazine in rats. Pharmacology 1979; 18: 125–35.
Mirmiran M, Brenner E, VanDerGugten J, Swaab DF. Neurochemical and electrophysiological disturbances mediate developmental behavioral alterations produced by medicines. Neurobehav Toxicol Teratol 1985; 7: 677–83.
Nakanishi H, Fujii T. Behavioral changes in juvenile rats after prenatal exposure to ethosuximide. Pharmacol Biochem Behav 1990; 36: 163–8.
Nomura Y, Takère Y, Nomura Y, Shinagawa S, Kaneko S, Sato T. The physical and mental development of infants born to mothers treated with antiepileptic drugs. In: Sato S, Shinagawa S, eds. Antiepileptic Drugs and Pregnancy. Amsterdam, The Netherlands: Excerpta Medica, 1984: 187–95.
Fujii T, Hara N, Kuga Y. Maternal exposure of rats to sodium valproate develops tolerance to valproate itself in the offspring. Proc Japan Acad 1986; 62B: 140–3.
Wallace JA, Lauder JM. Development of serotonergic sys-tem in the rat embryo: An immunocytochemical study. Brain Res Bull 1983; 10: 459–79.
Coyle JT, Henry D. Catecholamines in fetal and newborn rat brain. J Neurochem 1973; 27: 61–7.
Fujii T, Kusama Y. Long-lasting effects on the brain of a single exposure to non-neuroactive compounds: Anticancer and immunosuppressive agents. In: Fujii T, Boer GJ, eds. Functional Neuroteratology of Short-termExposure to Drugs. Tokyo, Japan: Teikyo University Press, 1991: 125–39.
Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th Ed. Hardman TG, Limbird LB, eds. New York, NY (USA): MacGraw-Hill, 1996: 411.
Rodier RM. Chronology of neuron development: Animal studies and their clinical implications. Dev Med Child Neurol 1980; 22: 525–45.
Kaldor JM, Day NE, Hemminki K. Quantifying the carcinogenicity of antineoplastic drugs. Eur J Cancer Clin Oncol 1988; 24: 703–11.
Watanabe T. Chemicals and carcinogenicity. J Practical Pharmacy 1990; 41: 7–29.
Ebert E, Leist KH, Mayer D. Summary of safety evaluation toxicity studies of glufosinate ammonium. Fd Chem Toxic 1990; 28: 339–49.
Fujii T. Biochemical and pharmacological assessment of transgenerational and latent functional disorders induced by man-made toxic agents. 1994 Report of Comprehensive Research on the Human and Earth, in Aid of Ministry of Education, Science, Sports and Culture. Tokyo, Japan, 1994: 286–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujii, T. Transgenerational effects of maternal exposure to chemicals on the functional development of the brain in the offspring. Cancer Causes Control 8, 524–528 (1997). https://doi.org/10.1023/A:1018477809755
Issue Date:
DOI: https://doi.org/10.1023/A:1018477809755